SPINT2 and non-small cell lung carcinoma: Moreover, NSCLC patients with deep tumor invasion (T3/T4) and high AJCC 8th stage (stages III/IV) had significantly lower expression of SPINT2 than these with superficial tumor invasion (T1/T2) and low AJCC 8th stage (stages I/II) (Fig. 6b).